Summary:

- A new study suggests that Ozempic-like drugs, which are typically used to treat type 2 diabetes, may also be effective in treating alcohol addiction.
- The study found that these drugs, known as glucagon-like peptide-1 (GLP-1) receptor agonists, can help reduce alcohol consumption and cravings in both animal models and human participants.
- The findings suggest that GLP-1 receptor agonists could potentially be a new therapeutic option for individuals struggling with alcohol addiction, providing a promising avenue for further research and development.